{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:42:01Z","timestamp":1792791721995,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":482,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003549","name":"Orsz\u00e1gos Tudom\u00e1nyos Kutat\u00e1si Alapprogramok (National Research Development and Innovation Office","doi-asserted-by":"publisher","award":["K119374"],"award-info":[{"award-number":["K119374"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Orsz\u00e1gos Tudom\u00e1nyos Kutat\u00e1si Alapprogramok (National Research Development and Innovation Office","doi-asserted-by":"publisher","award":["K119386"],"award-info":[{"award-number":["K119386"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union and the State of Hungary, co-financed by the European Regional Development Fund","award":["VEKOP-2.3.2-16-2017-00014"],"award-info":[{"award-number":["VEKOP-2.3.2-16-2017-00014"]}]},{"name":"National Development Agency","award":["KMOP-4.2.1\/B-10-2011-0002"],"award-info":[{"award-number":["KMOP-4.2.1\/B-10-2011-0002"]}],"id":[{"id":"https:\/\/ror.org\/018graf05","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1074\/jbc.ra119.008315","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T19:45:33Z","timestamp":1554493533000},"page":"8227-8237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors"],"prefix":"10.1016","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8758-6387","authenticated-orcid":false,"given":"D\u00e1vid","family":"Szak\u00e1cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kocsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-6017","authenticated-orcid":false,"given":"R\u00f3bert","family":"Sz\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"G\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-7971","authenticated-orcid":false,"given":"G\u00e1bor","family":"P\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.008315_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I\u2014molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II\u2014role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.imlet.2010.03.012","article-title":"The non-classical functions of the classical complement pathway recognition subcomponent C1q","volume":"131","author":"Nayak","year":"2010","journal-title":"Immunol. Lett"},{"key":"10.1074\/jbc.RA119.008315_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.ai.2017.06.004","article-title":"Complement system in neural synapse elimination in development and disease","volume":"135","author":"Presumey","year":"2017","journal-title":"Adv. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A journey through the lectin pathway of complement-MBL and beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol. Rev"},{"key":"10.1074\/jbc.RA119.008315_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00281-017-0661-x","article-title":"The properdin pathway: an \u201calternative activation pathway\u201d or a \u201ccritical amplification loop\u201d for C3 and C5 activation?","volume":"40","author":"Harrison","year":"2018","journal-title":"Semin. Immunopathol"},{"key":"10.1074\/jbc.RA119.008315_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.imbio.2018.02.001","article-title":"Looking back on the alternative complement pathway","volume":"223","author":"Lachmann","year":"2018","journal-title":"Immunobiology"},{"key":"10.1074\/jbc.RA119.008315_bib9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01851","article-title":"Be on target: strategies of targeting alternative and lectin pathway components in complement-mediated diseases","volume":"9","author":"Dob\u00f3","year":"2018","journal-title":"Front. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrneph.2017.156","article-title":"The renaissance of complement therapeutics","volume":"14","author":"Ricklin","year":"2018","journal-title":"Nat. Rev. Nephrol"},{"key":"10.1074\/jbc.RA119.008315_bib12","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1021\/acs.jmedchem.8b00560","article-title":"New analogs of the complement C3 inhibitor compstatin with increased solubility and improved pharmacokinetic profile","volume":"61","author":"Berger","year":"2018","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.RA119.008315_bib13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.008315_bib14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"T\u00fcz\u00fcn","year":"2013","journal-title":"Autoimmun. Rev"},{"key":"10.1074\/jbc.RA119.008315_bib15","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.4049\/jimmunol.174.10.6373","article-title":"Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q","volume":"174","author":"Hart","year":"2005","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib16","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1073\/pnas.1101748108","article-title":"Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia\/reperfusion injury","volume":"108","author":"Schwaeble","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008315_bib17","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1096\/fj.13-246306","article-title":"Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4","volume":"28","author":"Asgari","year":"2014","journal-title":"FASEB J"},{"key":"10.1074\/jbc.RA119.008315_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12974-016-0684-6","article-title":"Mannan binding lectin-associated serine protease-2 (MASP-2) critically contributes to post-ischemic brain injury independent of MASP-1","volume":"13","author":"Orsini","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1074\/jbc.RA119.008315_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40246-016-0079-x","article-title":"AMD and the alternative complement pathway: genetics and functional implications","volume":"10","author":"Tan","year":"2016","journal-title":"Hum. Genomics"},{"key":"10.1074\/jbc.RA119.008315_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0030-1262886","article-title":"Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes","volume":"36","author":"Le Quinterec","year":"2010","journal-title":"Semin. Thromb. Hemost"},{"key":"10.1074\/jbc.RA119.008315_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nchem.217","article-title":"The rise of fragment-based drug discovery","volume":"1","author":"Murray","year":"2009","journal-title":"Nat. Chem"},{"key":"10.1074\/jbc.RA119.008315_bib22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nchembio.2208","article-title":"Small-molecule factor D inhibitors targeting the alternative complement pathway","volume":"12","author":"Maibaum","year":"2016","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.RA119.008315_bib23","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.4049\/jimmunol.1001819","article-title":"Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation","volume":"185","author":"Kocsis","year":"2010","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib24","doi-asserted-by":"crossref","first-page":"20290","DOI":"10.1074\/jbc.M112.354332","article-title":"Monospecific inhibitors show that both mannan-binding lectin-associated serine protease-1 (MASP-1) and -2 are essential for lectin pathway activation and reveal structural plasticity of MASP-2","volume":"287","author":"H\u00e9ja","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008315_bib25","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1073\/pnas.1202588109","article-title":"Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2","volume":"109","author":"H\u00e9ja","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008315_bib26","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.4049\/jimmunol.0900879","article-title":"Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function","volume":"183","author":"Megyeri","year":"2009","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020036","article-title":"Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1","volume":"6","author":"Dob\u00f3","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA119.008315_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191292","article-title":"MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model","volume":"13","author":"Jenny","year":"2018","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA119.008315_bib29","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.4049\/jimmunol.1701421","article-title":"Cutting edge: a new player in the alternative complement pathway, MASP-1 is essential for LPS-induced, but not for zymosan-induced, alternative pathway activation","volume":"200","author":"Par\u00e9j","year":"2018","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2249.2012.04584.x","article-title":"Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components","volume":"169","author":"Thiel","year":"2012","journal-title":"Clin. Exp. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/eji.201445070","article-title":"TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2","volume":"45","author":"Keizer","year":"2015","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep31877","article-title":"MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked","volume":"6","author":"Dob\u00f3","year":"2016","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA119.008315_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.RA119.008315_bib34","doi-asserted-by":"crossref","first-page":"8950","DOI":"10.1073\/pnas.160252097","article-title":"Rapid mapping of protein functional epitopes by combinatorial alanine scanning","volume":"97","author":"Weiss","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008315_bib35","doi-asserted-by":"crossref","first-page":"22378","DOI":"10.1074\/jbc.M603826200","article-title":"Comprehensive and quantitative mapping of energy landscapes for protein-protein interactions by rapid combinatorial scanning","volume":"281","author":"P\u00e1l","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008315_bib36","doi-asserted-by":"crossref","first-page":"22535","DOI":"10.1074\/jbc.M111.235754","article-title":"High-affinity small protein inhibitors of human chymotrypsin C (CTRC) selected by phage display reveal unusual preference for P4\u2032 acidic residues","volume":"286","author":"Szab\u00f3","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008315_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jmb.2018.12.003","article-title":"Directed evolution of canonical loops and their swapping between unrelated serine proteinase inhibitors disprove the interscaffolding additivity model","volume":"431","author":"Boros","year":"2019","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.RA119.008315_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-1759(01)00453-7","article-title":"An assay for the mannan-binding lectin pathway of complement activation","volume":"257","author":"Petersen","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1074\/jbc.RA119.008315_bib39","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.molimm.2003.10.013","article-title":"Differential substrate and inhibitor profiles for human MASP-1 and MASP-2","volume":"40","author":"Presanis","year":"2004","journal-title":"Mol. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015443","article-title":"Functional analysis of Ficolin-3 mediated complement activation","volume":"5","author":"Hein","year":"2010","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA119.008315_bib41","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/JCM.01985-09","article-title":"Sodium polyanethole sulfonate as an inhibitor of activation of complement function in blood culture systems","volume":"48","author":"Palarasah","year":"2010","journal-title":"J. Clin. Microbiol"},{"key":"10.1074\/jbc.RA119.008315_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2017-000652","article-title":"Cardioprotection by an anti-MASP-2 antibody in a murine model of myocardial infarction","volume":"5","author":"Clark","year":"2018","journal-title":"Open Heart"},{"key":"10.1074\/jbc.RA119.008315_bib43","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.112.123968","article-title":"Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis","volume":"126","author":"Pavlov","year":"2012","journal-title":"Circulation"},{"key":"10.1074\/jbc.RA119.008315_bib44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ajpath.2014.10.015","article-title":"Human mannose-binding lectin inhibitor prevents myocardial injury and arterial thrombogenesis in a novel animal model","volume":"185","author":"Pavlov","year":"2015","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.RA119.008315_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021338","article-title":"Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients","volume":"6","author":"Osthoff","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA119.008315_bib46","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.molimm.2013.01.008","article-title":"Association between lectin complement pathway initiators, C-reactive protein and left ventricular remodeling in myocardial infarction\u2014a magnetic resonance study","volume":"54","author":"Schoos","year":"2013","journal-title":"Mol. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijcard.2011.11.032","article-title":"MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humans","volume":"166","author":"Zhang","year":"2013","journal-title":"Int. J. Cardiol"},{"key":"10.1074\/jbc.RA119.008315_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01151","article-title":"The lectin pathway of complement in myocardial ischemia\/reperfusion injury\u2014review of its significance and the potential impact of therapeutic interference by C1 esterase inhibitor","volume":"9","author":"Panagiotou","year":"2018","journal-title":"Front. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib49","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/bi9620870","article-title":"Interscaffolding additivity: association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases","volume":"36","author":"Qasim","year":"1997","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA119.008315_bib50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2174\/0929866054395383","article-title":"The role of scaffolding in standard mechanism serine proteinase inhibitors","volume":"12","author":"Kelly","year":"2005","journal-title":"Protein Pept. Lett"},{"key":"10.1074\/jbc.RA119.008315_bib51","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.biochi.2010.05.003","article-title":"Phage display as a powerful tool to engineer protease inhibitors","volume":"92","author":"Zani","year":"2010","journal-title":"Biochimie"},{"key":"10.1074\/jbc.RA119.008315_bib52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1517\/17425255.4.7.871","article-title":"Species selection considerations for preclinical toxicology studies for biotherapeutics","volume":"4","author":"Bussiere","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"10.1074\/jbc.RA119.008315_bib53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1091581809337262","article-title":"Alternative strategies for toxicity testing of species-specific biopharmaceuticals","volume":"28","author":"Bussiere","year":"2009","journal-title":"Int. J. Toxicol"},{"key":"10.1074\/jbc.RA119.008315_bib54","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1021\/bi00485a001","article-title":"Regulation of coagulation by a multivalent Kunitz-type inhibitor","volume":"29","author":"Broze","year":"1990","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA119.008315_bib55","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor","volume":"338","author":"Girard","year":"1989","journal-title":"Nature"},{"key":"10.1074\/jbc.RA119.008315_bib56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/jmbi.1997.1029","article-title":"The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa","volume":"269","author":"Burgering","year":"1997","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.RA119.008315_bib57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrd3125","article-title":"Ecallantide","volume":"9","author":"Zuraw","year":"2010","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.RA119.008315_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4137\/CMC.S4434","article-title":"Ecallantide for the treatment of hereditary angiodema in adults","volume":"5","author":"Lunn","year":"2011","journal-title":"Clin. Med. Insights Cardiol"},{"key":"10.1074\/jbc.RA119.008315_bib59","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.V78.2.387.387","article-title":"Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples","volume":"78","author":"Novotny","year":"1991","journal-title":"Blood"},{"key":"10.1074\/jbc.RA119.008315_bib60","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4049\/jimmunol.0901141","article-title":"MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity","volume":"183","author":"Dob\u00f3","year":"2009","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib61","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4049\/jimmunol.170.3.1374","article-title":"Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments","volume":"170","author":"Ambrus","year":"2003","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib62","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4049\/jimmunol.1501717","article-title":"MASP-1 and MASP-2 do not activate pro-factor D in resting human blood, whereas MASP-3 is a potential activator: kinetic analysis involving specific MASP-1 and MASP-2 inhibitors","volume":"196","author":"Oroszl\u00e1n","year":"2016","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.imbio.2006.11.002","article-title":"Serine proteases of the classical and lectin pathways: similarities and differences","volume":"212","author":"G\u00e1l","year":"2007","journal-title":"Immunobiology"},{"key":"10.1074\/jbc.RA119.008315_bib64","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res"},{"key":"10.1074\/jbc.RA119.008315_bib65","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1073\/pnas.82.2.488","article-title":"Rapid and efficient site-specific mutagenesis without phenotypic selection","volume":"82","author":"Kunkel","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008315_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/intimm\/dxl131","article-title":"Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway","volume":"19","author":"M\u00f8ller-Kristensen","year":"2007","journal-title":"Int. Immunol"},{"key":"10.1074\/jbc.RA119.008315_bib67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jim.2004.11.016","article-title":"Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA","volume":"296","author":"Seelen","year":"2005","journal-title":"J. Immunol. Methods"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820363754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820363754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.008315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T02:56:48Z","timestamp":1641265008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820363754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":67,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0021925820363754"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.008315","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.008315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Szak\u00e1cs et al.","name":"copyright","label":"Copyright"}]}}